Showing posts with label India. Show all posts
Showing posts with label India. Show all posts

Wednesday, October 29, 2014

Posture Guru Takes On the Office Slouch

Mark O. Hatfield Research Center at the Oregon...
Mark O. Hatfield Research Center at the Oregon Health & Scienc University in Portland, OR. (Photo credit: Wikipedia)
English: This is one of the huge welcoming sig...
English: This is one of the huge welcoming signs for Google plex in the silicon valley. (Photo credit: Wikipedia)
Oregon Health Sciences University.
Oregon Health Sciences University. (Photo credit: Wikipedia)
English: Apple's headquarters at Infinite Loop...
English: Apple's headquarters at Infinite Loop in Cupertino, California, USA. (Photo credit: Wikipedia)
Palo Alto Medical Foundation Campus Photo
Palo Alto Medical Foundation Campus Photo (Photo credit: Wikipedia)
Oracle Corporation world HQ
Oracle Corporation world HQ (Photo credit: Wikipedia)
By AMY SCHOENFELD


Office workers around the world are chained to their technology, hunched over desktop, laptops, smartphone, and tablet, and it’s all taken a toll on their bodies.

Esther Gokhale, 52, a posture guru in Silicon Valley, believes that people suffer from pain and dysfunction because they have forgotten how to use their bodies. It’s not the act of sitting for long periods that causes us pain, she says, it’s the way we position ourselves.

Ms. Gokhale is not helping aching office workers with high-tech gadgets and medical therapies. Rather, she says she is reintroducing her clients to what she calls “primal posture” – a way of holding themselves that is shared by older babies and toddlers, and that she says was common among our ancestor before slouching became a way of life. It is also a posture that Ms. Gokhale observed during research she conducted in a dozen other countries, as well as in India, where she was raised.

Her method, based not on technology but primarily on observations of people, has been embraced by executives, board members and staff members at some of Silicon Valley’s biggest companies, including Google and Oracle; and heavy users of technology.

--------------------
GOKHALE METHOD
Clients sit upright and relaxed with a forward-tilting pelvis and a well-stacked spine.
--------------------

“I need to do things that make sense and that I can see results from. Esther’s work is like that,” said Susan Wojcicki, 44, one of Google’s senior vice president, who has suffered from back and neck pain that she attributes to doing too much work at her desk.

Ms. Gokhale is not the first to suggest that changing posture is the key to a healthy spine. Practitioners of the Alexander Technique and the creators of the Aplomb Institute in Paris similarly help clients find more natural and comfortable ways to position themselves. Pilates and physical therapy can improve posture and bring awareness to it. A handful of companies, like Lumo BodyTech, sell posture monitors, offering smartphone users feedback about the way they hold their bodies.

--------------------
SLUMPED
Ms. Gokhale says that many people sit on a tucked pelvis with a C-shaped spine.
--------------------

Ms. Gokhale’s methods have not been tested scientifically, though a doctor at the Palo Alto Medical Foundation is planning on conducting clinical trials by the end of the year.

Backaches affect most Americans – about 8 in 10 deal with the pain at some point in their lifetimes, said Dr. Richard Deyo, a professor at Oregon Health and Science University.

The expenses are huge as well. By one estimate that appeared in The Journal of the American Medical Association, the national cost of treating people with back and neck pain was $86 billion in 2005 in the United States. And with back pain one of the top reasons for worker disability, missed work because of these aches may cost employers close to $7 billion a year, according to one study.

--------------------
TENSE
Others sit tensely on a tucked pelvis with an arched back (like an S shape).
--------------------

For most people with back pain, the aches are short-lived, Dr. Deyo said. But methods to help those with chronic pain are diverse. Using a standing desk at work has become a popular way to ease discomfort. Exercise, yoga, acupuncture and chiropractic have also been shown to reduce pain. Medical treatments continue to be important option, doctors says, even amid concerns that these have been overused.
Ms. Gokhale had to deal with her own pain in her lower back, first as a college student practicing yoga, then as a young mother with sciatica. She eventually had surgery for a herniated disk, but it failed, she said. When doctors suggested she try a second time, Ms. Gokhale began a search for other answers.

In Ms. Gokhale’s courses, students relearn how to sit, stand, sleep and walk. She says most people tend to be relaxed and slumped (think of a C-shaped spine), or arched up and tense (an S shape), the stand-up-straight style of posture that some parents demand on their children. She helps her students return their bodies to the stance that she says nature intended: upright and relaxed (a tall J spine).

With care, Ms. Gokhale adjusts clients’ bodies from the bottom to top. She helps clients relax the front of the pelvis downward, so the belt line slants forward and the butt angles back, so “your behind is behind you, not under you.”

Ms. Gokhale guides students’ rib cages that sway too far back, so they are flush with the stomach. She takes their hunched shoulders, rolls them up and brings them gently back and down. And she helps student release tension in their necks by recentering their heads over their spines and pulling upward slightly. The result is an elongated and well-stacked spine that many students say they can maintain.

Ray Bingham, 67, the presiding director of Oracle’s board, was referred to Ms. Gokhale last fall for his lower back pain. Mr. Bingham says he has found relief after using her methods and he diligently practices his newfound ways of sitting, walking and standing.

“This is not an approach like physical therapy with a beginning and an end; this is a new way of being from now on,” Mr. Bingham said.


Taken from TODAY, Saturday Edition, June 1, 2013

Thursday, March 28, 2013

Drug trials in India "causing havoc to human life"

Posted: 03 January 2013


Indians sit near the sea front as dark clouds gather over the city skyline in Mumbai. (AFP/Punit Paranjpe)
NEW DELHI: India's Supreme Court said Thursday that unregulated clinical trials of new drugs were causing "havoc" in the country as it ordered the health ministry to monitor any new applications for tests.

The comments were made during a hearing on a petition detailing deaths and health problems caused by clinical trials carried out on Indians, often without their knowledge or consent.

"Uncontrolled clinical trials are causing havoc to human life," Justice R.M. Lodha observed.

"There are so many legal and ethical issues involved with clinical trials and the government has not done anything so far."

The judge, who has previously stated that Indians are being used like "guinea pigs", ordered the health secretary to monitor all new applications for trials from pharmaceutical companies.

Low costs, weak laws and inadequate enforcement and penalties have made India an attractive destination for the tests, activists say.

The petitioners in the public interest litigation case -- a group of doctors and a voluntary organisation -- claim several patients seeking medical help in the central state of Madhya Pradesh were used in drug tests.

The groups say they have compiled and submitted a report on more than 200 cases in which patients were subjected to trials to check the efficacy of various new treatments without their permission.

Drug trials are an essential step for pharmaceutical companies in order to win regulatory approval to bring new drugs to market.

Earlier this year, 12 doctors were accused of conducting secret trials on children and patients with learning disabilities. They paid fines of less than US$100 each.

Faced with mounting criticism, the Indian Council of Medical Research in 2011 sought proposals from doctors and health activists on new draft guidelines for compensation for people used in drug trials.

-AFP/fl



-----
Taken from ChannelNewsAsia.com; source article is below:
Drug trials in India "causing havoc to human life"

Enhanced by Zemanta

Wednesday, December 14, 2011

'TB sniffer' offers hope of early diagnosis

Posted: 08 November 2011

Indian medical nurses display placards in Hyderabad. (AFP Photo/Noah Seelam)
NEW DELHI: Indian researchers said on Monday they were close to developing an "electronic nose" to sniff out tuberculosis on the breath - offering rapid diagnosis that could save hundreds of thousands of lives.

The "E-Nose" is a battery-operated, hand-held unit, similar to a police breathalyser used to catch drunk drivers.

A patient blows into the device and sensors pick up TB biomarkers in the breath droplets, resulting in an almost instantaneous and highly accurate diagnosis.

The "E-Nose" is a collaboration between the International Centre for Genetic Engineering and Biotechnology in New Delhi and Next Dimension Technologies in California.

"We hope to have a prototype ready for clinical testing by October 2013," said lead researcher Ranjan Nanda.

TB kills close to 1.7 million people globally every year, and researchers estimate the "E-Nose" could save 400,000 lives a year in developing countries through early diagnosis, treatment and reduced transmission.

TB is currently detected through sputum tests that are costly and take several days.

On Monday, the project was awarded a $950,000 grant by the Bill and Melinda gates Foundation and Grand Challenges Canada, a non-profit organisation working on health issues in the developing world.

"Our research shows it might also be possible to use this technology for the early detection of other diseases like lung cancer and pneumonia," Nanda told AFP.

Each "E-Nose" would cost roughly $20-30 and its size and battery operation would make it accessible to rural communities in countries such as India with poor or non-existent power supplies.

According to the World Health organisation, India leads the world in TB infections which kill close to 1,000 people every day.

"Our goal is to make the Electronic Nose widely available in poor, remote areas where tuberculosis often breeds and spreads, devastating so many lives," Nanda said.

Tuberculosis is a contagious bacterial infection that spreads through the air. If left untreated, each person with active TB will on average infect between 10 and 15 people every year, according to the WHO.

- AFP/de



Taken from ChannelNewsAsia.com; source article is below:
'TB sniffer' offers hope of early diagnosis

Enhanced by Zemanta

Sunday, November 14, 2010

New polio vaccine raises hope for eradication: study

New medicine brings new hope... will it deliver?
-----

The Polio Paradox: What You Need to KnowPolio: An American StoryBROKEN WINGSExploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop ReportDirt and Disease: Polio Before FDR (Health and Medicine in American Society)PARIS - A new polio vaccine offers superior immunisation and is raising hopes of a total eradication of the disease, according to a study published on Tuesday by British medical journal The Lancet.

There are three types of the polio virus, and while type 2 has been almost entirely eradicated since mass vaccinations began in 1988, types 1 and 3 remain a global health threat.

The new bivalent vaccine targets types 1 and 3, and was shown to be significantly more effective than the common trivalent vaccine in a 2008 trial in India.

In the trial, conducted by experts from the World Health Organisation and India, 830 new-born babies at three medical centres were given either existing vaccines or the new bivalent vaccine.

The new vaccine presented immunity against type 1 polio in 90 per cent of babies, compared with 63 per cent from the trivalent vaccine.

The new vaccine presented 74 per cent immunity for type 3, against 52 per cent with the trivalent vaccine. A monovalent vaccine for type 3 led to 84 per cent immunity.

Polio is a pandemic threat in four countries, namely India, Afghanistan, Pakistan and Nigeria, compared to 125 countries in 1988. There were 1,606 cases of polio last year, down from about 350,000 in 1988.

The new vaccine is already being widely used in India, and the number of polio cases was down to 32 so far this year, from 260 last year, the journal said, quoting researchers Nigel Crawford and Jim Buttery from the Murdoch Children's Research Institute in Melbourne, Australia.

The researchers warned that progress in polio immunisation was being undermined by a lack of funds, and called for a "final, concerted effort" to stamp it out.

- AFP/al


From ChannelNewsAsia.com; source article is below:
New polio vaccine raises hope for eradication: study
-----



Enhanced by Zemanta

Tuesday, October 19, 2010

Dengue fever spreading in Asia

NEW DELHI - Dengue fever, a mosquito-borne disease with no known treatment, is spreading in Asia, with cases in India at a 20-year high as the country hosts the Commonwealth Games.

The World Health Organisation (WHO) has warned that 2.5 billion people are at risk from one of the world's fastest-emerging infections, which has "grown dramatically in recent decades."

Officials at the WHO say Asia, home to 70 per cent of the at-risk population, has seen a rise in dengue mainly because of higher temperatures due to climate change, rising populations and greater international travel.

The organisation says "a rapid rise in urban mosquito populations" is also bringing ever greater numbers of people into contact with the virus.

According to data collected by the UN body, the highest number of reported cases in Asia this year to August are in Indonesia (80,065) followed by Thailand (57,948) and Sri Lanka (27,142).

Dengue, transmitted to humans by the female Aedes mosquitoes, causes a severe flu-like illness for most victims that lasts about a week. There are four strains, one of which is a potentially lethal haemorrhagic type.

"The disease has spread fast. Dengue is appearing in new areas," said Yogesh Choudhri, an expert at the WHO on the Asia region, who said the disease had crossed new international borders and spread within countries.

It was found in the Himalayan countries of Bhutan and Nepal for the first time in 2004, and is endemic in most of Southeast and South Asia as well as Indonesia and East Timor.

In India, government hospitals in New Delhi are overflowing with dengue victims as the city hosts 7,000 foreign athletes and officials for the Commonwealth Games, which finish next Thursday.

A.C. Dhariwal, director of India's National Vector-Borne Disease Control Programme, told AFP that cases in India were at a 20-year high, with 50 people dead and 12,000 reported infections. The number of actual infections is likely to be far higher.

He blamed the delayed construction work for the Commonwealth Games for part of the problem in New Delhi, where monsoon rains have been at their strongest in years.

"Delays in Games construction and urban improvement projects are to blame for the severe dengue outbreak since mounds of rubble and puddles are strewn across the city," he said.

Last week an official with the Indian lawn bowls squad contracted dengue, the first person associated with the Games to to do so.

There is no known treatment for dengue, but several preventative steps can be taken. The most important is to ensure there is no standing water near residential areas where mosquitoes breed.

Spraying insecticide, an approach taken by many city authorities, can also help, as does applying mosquito repellent and wearing long sleeves and trousers.

In Thailand, the government is worried about a South Korean-inspired fashion craze for black leggings which could be putting teenagers at risk.

"I'm worried about how people dress, especially teenagers," said Deputy Public Health Minister Phansiri Kulanartsiri, noting that the mosquitoes which transmit the disease are attracted by dark colours.

"The mosquitoes can bite through the leggings' thin fabric, so those who wear them are at greater risk of being infected with dengue."

In Sri Lanka, authorities have introduced heavy fines for people with standing water in their homes, and troops have been deployed to clean up public places.

Malaysia has reported a 53-per cent rise in dengue-related deaths this year, but backed away from a controversial trial of releasing genetically modified mosquitoes to wipe out the disease.

In the first experiment of its kind in Asia, 2,000-3,000 modified male Aedes aegypti mosquitoes were to have been released in two Malaysian states in October or November.

The offspring of the mosquitoes would have died quickly, curbing the growth of the population in a technique researchers hope could eventually eradicate the dengue mosquito altogether. But the government scrapped the idea after complaints from environmentalists.

Health authorities in Bangladesh said dengue prevalence was on the rise but fatalities were down.

Surveys conducted by the health ministry indicate that the dengue prevalence rate was 3.4 per cent in 2006, rising to 5.25 per cent in 2007, and by 2009 to 9.1 per cent.

The number of dengue fever patients in South Korea and Japan remains small but is rising as more travel overseas, especially to Southeast Asia and Latin America.

- CNA/al


From ChannelNewsAsia.com; source article is below:
Dengue fever spreading in Asia
-----



Enhanced by Zemanta

Sunday, September 19, 2010

Improved tests to save from ovarian cancer

New and improved test to save women from ovarian cancer

Blood samples
SINGAPORE: The fight against ovarian cancer gets a shot in the arm with the development of a new test, said to be able to detect early stages of the disease with a more than 90 percent accuracy.

Called OvPlex, it is developed by Australian biotechnology company HealthLinx Limited in association with Healthscope, and it uses blood to detect the presence of cancer.

OvPlex is billed as the world's first five-biomarker test. What it means is that the system measures five different substances in the blood associated with ovarian cancer, instead of just one in commonly-used tests.

The new blood test was launched by Innovations Exchange (INEX), a leading women's health molecular diagnostic spin-off from the National University of Singapore (NUS).

Associate Professor Mahesh Choolani, chairman of INEX, said: "Currently, we use CA-125, which is meant for monitoring the disease, detection of recurrence and while CA-125 is ok for patients with advanced cancer, it's actually not very good for patients with early cancer."

He said data suggests CA-125 detects 50 per cent or less of early stage ovarian cancer, adding that there are other factors that affect CA-125's accuracy.

"Common conditions like endometriosis, pelvic infections, can actually alter the CA-125 as well, making it even less effective," he said.

Associate Professor Mahesh Choolani said that for OvPlex, with additional biomarkers, the detection rate of early ovarian cancer is increased.

And compared to CA-125, the new test lowers the false positive and false negative rates by about 30 per cent each.

Costing S$300, the 10-minute blood test that will be conducted at Quest Laboratories is already available at selected GPs and specialists in Singapore. Public hospitals and clinics will offer it by the end of the year.

Results will take up to 15 days. The new blood test is also available in Australia and the United Kingdom.

Singapore is the third country in the world to offer the test and the country will serve as a launch pad for the region including India, Malaysia and Vietnam.

Ovarian cancer is a rapidly growing problem throughout Asia. It is also the most lethal of all gynaecological cancers since the possibility of a cure in the later stages is low.

Three in four women with the disease are detected in the late stages and doctors are worried because in the late stages, only 30 per cent of women survive past five years. But if detected early, the survival rate is more than 90 per cent.

Ovarian cancer is the fifth most common cancer affecting women in Singapore.

Every year in Singapore, about 265 women are diagnosed with ovarian cancer, and nearly 100 women die from the disease.

Between 2003 and 2007, there were a total of 1,327 ovarian cancer cases and 471 patients died.


- CNA/ir


From ChannelNewsAsia.com; source article is below:New and improved test to save women from ovarian cancer
-----



Enhanced by Zemanta

Sunday, September 5, 2010

Superbugs - not in Singapore!

Well, this is a relief! I presently live in this country, and I'm relieved to know that it's not here, no sir!
-----

Plastic surgeons see low risk of catching superbug in S'pore
SINGAPORE : UK scientists have recently uncovered an antibiotic-resistant superbug.

They believe it was brought into Britain by health tourists who had travelled to India or Pakistan for cosmetic surgery.

But plastic surgeons in Singapore say the risk of infection here is low - for now. They say medicated soap and steam cleaners can help to reduce the chances of infection.

And they believe the environment in India and the nature of the surgery may have contributed to the spread of the superbug.

They say major operations would bring a higher risk of infection, while surgeries in small clinics carry less risk.

Dr Chua Jun Jin, a plastic surgeon, said: "This superbug comes (mostly) from invasive procedures, prolonged hospitalisation in an intensive care unit for patients who've been staying there for a long time with multiple diseases, like kidney diseases, diabetes to heart diseases.

"Therefore, when you have surgery in a small clinic, the risk of you contracting this multi-resistant superbug is very small."

Dr Chua also said few Singaporeans go to South Asia for cosmetic surgery. He said some seeking to pay less would go to Thailand or China, while those who want to look like Korean stars would go to South Korea.

However, he urged those who go for plastic surgery abroad to be cautious as they may not know the medical situation there well.

- CNA/al


From ChannelNewsAsia.com; source article is below:Plastic surgeons see low risk of catching superbug in S'pore
-----



Enhanced by Zemanta

Superbugs!

New superbugs spreading from South Asia
LONDON - "Health tourists" flocking to south Asia have carried a new class of antibiotic-resistant superbugs to Britain, researchers reported Wednesday, warning that the bacteria could spread worldwide.

Many hospital infections that were already difficult to treat have become even more impervious to drugs due to a recently discovered gene that can jump across different species of bacteria.

This so-called NDM-1 gene was first identified last year by Cardiff University's Timothy Walsh in two types of bacteria -- Klebsiella pneumoniae and Escherichia coli -- in a Swedish patient admitted to hospital in India.

Worryingly, the new NDM-1 bacteria are resistant even to carbapenems, a group of antibiotics often reserved as a last resort for emergency treatment for multi-drug resistant bugs.

Researchers said the bugs had been brought into Britain by patients who travelled to India or Pakistan for cosmetic surgery.

"If these infections were allowed to continue without appropriate treatment, then certainly one would expect to see some sort of mortality," Walsh, a microbiology professor, told BBC radio.

"It's going to be very difficult to treat the infections once the patients present with these types of bacteria. You won't get well."

In the new study, led by Walsh and Madras University's Karthikeyan Kumarasamy, researchers set out to determine how common the NDM-1 producing bacteria were in South Asia and Britain, where several cases had turned up.

Checking hospital patients with suspect symptoms, they found 44 cases -- 1.5 percent of those screened -- in Chennai, and 26 (eight percent of those screened) in Haryana, both in India.

They likewise found the superbug in Bangladesh and Pakistan, as well as 37 cases in Britain, some in patients who had recently returned from having cosmetic surgery in India or Pakistan.

"India also provides cosmetic surgery for other Europeans and Americans, and it is likely that NDM-1 will spread worldwide," said the study, published in British medical journal The Lancet.

NDM-1 was mostly found in E. coli, a common source of community-acquired urinary tract infections, and K. pneumoniae, and was impervious to all antibiotics except two, tigecycline and colistin.

In some cases, even these drugs did not beat back the infection.

"We've actually almost run out of antibiotics. We only have two left and one isn't particularly good," Walsh told the BBC.

Crucially, the NDM-1 gene was found on DNA structures, called plasmids, that can be easily copied and transferred between bacteria, giving the bug "an alarming potential to spread and diversify," the authors said.

"Unprecedented air travel and migration allow bacterial plasmids and clones to be transported rapidly between countries and continents," they said, adding that most could remain undetected.

The emergence of these new drug-resistant strains could become a serious global public health problem as the major threat shifts toward a broad class of bacteria -- including those armed with the NDM-1 gene -- known as "Gram-negative", the researchers warn.

"There are few new anti-Gram-negative antibiotics in development, and none that are effective against NDM-1," the study said.

NDM-1 stands for New Delhi metallo-beta-lactamase-1.

"We believe it's present within the community within India -- not just within the hospitals," Walsh said.

The professor said that looking ahead to what might be available to treat NDM-1, "there are no new antibiotics that are going to be available in 10 years' time".

He added: "We desperately need -- in the 21st century it sounds ridiculous that we don't have -- a globally-funded surveillance system.

"Secondly, there is a desperate need for new and novel antibiotics targeted towards these types of bacteria."

- AFP /ls


From ChannelNewsAsia.com; source article is below:New superbugs spreading from South Asia
-----



Enhanced by Zemanta